Journal of Global Infectious DiseasesOfficial Publishing of INDUSEM and OPUS 12 Foundation, Inc. Users online:983  
Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size     
Home About us Editors Ahead of Print Current Issue Archives Search Instructions Subscribe Advertise Login 
 


 
   Table of Contents     
EDITORIAL  
Year : 2015  |  Volume : 7  |  Issue : 4  |  Page : 125-126
State of the globe: The rippling effect of multidrug-resistant gram-negative infections


Division of Infectious Diseases, Moffitt Cancer Center, Tampa, FL, USA

Click here for correspondence address and email

Date of Web Publication25-Nov-2015
 

How to cite this article:
Baluch A. State of the globe: The rippling effect of multidrug-resistant gram-negative infections. J Global Infect Dis 2015;7:125-6

How to cite this URL:
Baluch A. State of the globe: The rippling effect of multidrug-resistant gram-negative infections. J Global Infect Dis [serial online] 2015 [cited 2019 Jul 20];7:125-6. Available from: http://www.jgid.org/text.asp?2015/7/4/125/170494


The continued emergence of multidrug-resistant (MDR) organisms in our hospital systems such as the Neonatal Intensive Care Unit as mentioned by Ramakrishnan et al. represents the need for continued vigilance and proactive plans to prevent the spread of these organisms. These multifaceted plans directed by infectious diseases teams have procedures in place via infection control, with subsequent components done in concert with microbiology labs and antimicrobial stewardship programs. If any of these moving parts are not appropriately coordinated then are lapses and patients pay for the consequences. Ramakrishnan's case series describes a 50% mortality rate to the youngest of possible age groups when an MDR strain of Klebsiella pneumoniae entered the microbiological flora of a single center.

Infection control interventions form the cornerstone to prevent the spread of MDR infections in a single facility. Hand hygiene and appropriate environmental cleaning, though basic are still very important. Numerous papers have cited increased transmission of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and other organisms as the percent of those participating in good hand hygiene decreases. [1] In Australia, the pooled acquisition odds ratio for Gram-negatives was found to be 2.65 (95% confidence interval: 2.02-3.47) reflecting the bacterial flora from the prior occupant of the same room. [2]

Once a patient has a presentation consistent with sepsis, empiric antimicrobials are chosen after cultures are drawn. Astute knowledge of the common flora related to a country or facility is needed in order to choose the appropriate entry level of antimicrobials. Understanding a particular patient's personal risk factors for MDR colonization as related to significant recent hospitalizations and/or previous receipt of broad-spectrum antimicrobials such as cephalosporins. [3] Bacteremia with MDR organisms can occur de novo as well and would not be picked up until blood cultures are finalized. Monitoring critically ill patients and readdressing the level of antimicrobials after approximately 48 h is an appropriate plan of care for such a situation. With standard microbiologic workup, there is often a lag of up to 48 h from the positivity of a blood culture to identification and sensitivity analysis with automated systems such as VITEK 2. There are an increasing number of platforms that utilize polymerase chain reaction (PCR) technology allowing for blood culture identification in approximately 1 h after Gram-stain production such as with the FilmArray system of Biofire (Biofire PDF). [4] Reproducible sensitivity and specificity are 95% and 96.7%, respectively, for different multiplex PCR kits but only for known targets of drug mechanisms. [5] Multiplex PCRs will miss novel mutations of MDR organisms as plasmids are exchanged or new mutations occur that otherwise would have been assessed phenotypically on plate cultures. Once an MDR organism is correctly identified, appropriate and timely therapy escalation is implemented if it had not already been done empirically. The use of aminoglycosides and polymixins as part of the concerted treatment for MDR organisms has increased the rates of acute kidney injury as well as other unmitigated side effects. In addition, there is added selective antimicrobial pressure from the ongoing use of carbapenems leading to further issues with potential infections with organisms such as Stenotrophomonas sp.

Despite interventions with aggressive hand hygiene and appropriately placed critical care bundles, bacteremias with MDR organisms continue to occur. Root cause analyses are important as well as looking to the future for further improvements. Having teams and protocols in place when a single aberration occurs compared to the norm of a hospital helps get in front of a potential catastrophe that includes loss of life. Considering the concentration of patients with MDR organisms in a hospital, appropriate disposal of patient bodily fluids becomes an added issue. Hospital effluent has been assessed and been found to be contaminated with high level of MDR Gram-negative organisms that a standard sewage plant would be unable to create protocols to neutralize thus allowing it to mix with other environmental substances. [6] The question of adequate assessing for and then treating MDR infections is an issue here to stay. Large steps have been made in diagnosing them faster, but further therapies are needed for treatment and minimizing spread within a hospital as well as the environment as a whole.

 
   References Top

1.
Sadeghi-Moghaddam P, Arjmandnia M, Shokrollahi M, Aghaali M. Does training improve compliance with hand hygiene and decrease infections in the neonatal intensive care unit? A prospective study. J Neonatal Perinatal Med 2015;8:221-5.  Back to cited text no. 1
    
2.
Mitchell BG, Dancer SJ, Anderson M, Dehn E. Risk of organism acquisition from prior room occupants: A systematic review and meta-analysis. J Hosp Infect 2015;91:211-7.  Back to cited text no. 2
    
3.
Ivády B, Kenesei É, Tóth-Heyn P, Kertész G, Tárkányi K, Kassa C, et al. Factors influencing antimicrobial resistance and outcome of gram-negative bloodstream infections in children. Infection 2015 [Epub ahead of print].  Back to cited text no. 3
    
4.
Available from: http://www.filmarray.com/assets/pdf/Info-Sheet-BCID-Panel-FLM1-PRT-0069-03.pdf. [Last accessed on 2015 Nov 22].  Back to cited text no. 4
    
5.
Chavada R, Maley M. Evaluation of a commercial multiplex PCR for rapid detection of multi drug resistant gram negative infections. Open Microbiol J 2015;9:125-35.  Back to cited text no. 5
    
6.
Vaz-Moreira I, Varela AR, Pereira TV, Fochat RC, Manaia CM. Multidrug Resistance in quinolone-resistant gram-negative bacteria isolated from hospital effluent and the municipal wastewater treatment plant. Microb Drug Resist 2015 [Epub ahead of print].  Back to cited text no. 6
    

Top
Correspondence Address:
Aliyah Baluch
Division of Infectious Diseases, Moffitt Cancer Center, Tampa, FL
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0974-777X.170494

Rights and Permissions




 

Top
  
 
  Search
 
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Email Alert *
    Add to My List *
* Registration required (free)  


    References

 Article Access Statistics
    Viewed1460    
    Printed25    
    Emailed0    
    PDF Downloaded16    
    Comments [Add]    

Recommend this journal

Sitemap | What's New | Feedback | Copyright and Disclaimer | Contact Us
2008 Journal of Global Infectious Diseases | Published by Wolters Kluwer - Medknow
Online since 10th December, 2008